Search - Archive ouverte HAL Access content directly

Filter your results

11 Results
authFullName_s : O. Caron

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1

Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

C. Bertolotto , F. Lesueur , S. Giuliano , T. Strub , Lichy M. De et al.
Nature, 2016, 531, pp.126. ⟨10.1038/nature16158⟩
Journal articles hal-01791271v1

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

C. Julian-Reynier , R. Fabre , I. Coupier , Dominique Stoppa-Lyonnet , Christine Lasset et al.
Genetics in Medicine, 2012, --, pp.5579-5592
Journal articles hal-00697969v1

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

C. Julian-Reynier , A. D. Bouhnik , E. Mouret-Fourme , M. Gauthier-Villars , P. Berthet et al.
Genetics in Medicine, 2010, 12, pp.801-807. ⟨10.1097/GIM.0b013e3181f48d1c⟩
Journal articles hal-02303688v1

French women breast self-examination practices with time after undergoing BRCA1/2 genetic testing

C. Maheu , Thémis Apostolidis , A. Petri-Cal , E. Mouret-Fourme , M. Gauthier-Villars et al.
Familial Cancer, 2012, 11, pp.269--278. ⟨10.1007/s10689-012-9512-z⟩
Journal articles istex hal-02289813v1

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations

J. Julian-Reynier , J. Mancini , E. Mouret-Fourme , M. Gauthier-Villars , Valérie Bonadona et al.
European Journal of Human Genetics, 2011, 19, pp.500-506. ⟨10.1038/ejhg.2010.241⟩
Journal articles hal-00697966v1

Germline \textitBAP1 mutations predispose to renal cell carcinomas

T. Popova , L. Hebert , V. Jacquemin , S. Gad , V. Caux-Moncoutier et al.
American Journal of Human Genetics, 2013, 92, pp.974--80. ⟨10.1016/j.ajhg.2013.04.012⟩
Journal articles hal-02282699v1

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

V. Bubien , F. Bonnet , V. Brouste , S. Hoppe , E. Barouk-Simonet et al.
Journal of Medical Genetics, 2013, 50, pp.255-63. ⟨10.1136/jmedgenet-2012-101339⟩
Journal articles istex hal-02168104v1

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families

G. Bougeard , R. Sesboué , S. Desurmont , P. Berthet , Valérie Bonadona et al.
Journal of Medical Genetic, 2008, 45, pp.535-538
Journal articles hal-00698382v1

Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours

J. Aury-Landas , G. Bougeard , H. Castel , Hector Hernandez-Vargas , A. Drouet et al.
European Journal of Human Genetics, 2013, 21, pp.1369-76. ⟨10.1038/ejhg.2013.68⟩
Journal articles hal-02088196v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1